Literature DB >> 15833090

Molecular pharmacology of topiramate: managing seizures and preventing migraine.

H Steve White1.   

Abstract

Topiramate is a neuromodulatory compound with stabilizing properties that was initially introduced for the management of partial seizures. Topiramate has been demonstrated to modify several receptor-gated and voltage-sensitive ion channels, including voltage-activated Na+ and Ca2+ channels and non-NMDA receptors. These receptors have been implicated in the pathophysiology of both epilepsy and migraine. The pharmacological mechanisms of action for topiramate that may explain its antiepileptic and migraine preventive activities will be discussed in this review. In addition, the potential relationship between the molecular activities of topiramate and its efficacy in epilepsy and migraine prevention will be emphasized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833090     DOI: 10.1111/j.1526-4610.2005.4501006.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  26 in total

1.  Retinal function and histopathology in rabbits treated with Topiramate.

Authors:  S Kjellström; A Bruun; B Isaksson; T Eriksson; S Andréasson; V Ponjavic
Journal:  Doc Ophthalmol       Date:  2006-11-18       Impact factor: 2.379

2.  Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study.

Authors:  Constance M Moore; Megan Wardrop; Blaise deB Frederick; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2006-08-31       Impact factor: 4.530

3.  Prophylactic treatment of migraine with topamax: long-term results.

Authors:  Yu E Azimova; G R Tabeeva
Journal:  Neurosci Behav Physiol       Date:  2007-02

4.  Involvement of group II metabotropic glutamate receptors in stress-induced behavioural sensitization.

Authors:  Rianne Stam; Robert P J de Lange; Haitske Graveland; Peternella S Verhave; Victor M Wiegant
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

5.  Topiramate: Safety in migraine patients.

Authors:  M Ahamada Safna Mariyam; Suchandra Sen; K Vijayan
Journal:  J Young Pharm       Date:  2013-03-06

6.  Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

Authors:  Amanda Boyd; Carolina Casselini; Etta Vinik; Aaron Vinik
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

Review 7.  Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements.

Authors:  Mustafa Nazıroğlu; Vedat Ali Yürekli
Journal:  Cell Mol Neurobiol       Date:  2013-04-14       Impact factor: 5.046

Review 8.  Medication overuse headache: awareness, detection and treatment.

Authors:  Alan M Rapoport
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.

Authors:  Chittaranjan Andrade; Savita G Bhakta; Praveen P Fernandes
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

10.  Modifications of antiepileptic drugs for improved tolerability and efficacy.

Authors:  Cecilie Johannessen Landmark; Svein I Johannessen
Journal:  Perspect Medicin Chem       Date:  2008-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.